Other
Neoplasm by Site
CI-CAN-00000003Explore in graph →
Non-malignant20,485 active trials253 approved drugs3,567 evidence items
Loading cancer entity…
Loading cancer entity…
Other
CI-CAN-00000003Explore in graph →
Clinical trials
92,566 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06963060 | Gem+Nab-P+LEN+TIS for Advanced Unresectable BTC (GALENT-BT)(GALENT-BT) | enrolling by invitation | Phase 2 | 44 | Wei GongOTHER | 1 | May 8, 2025 | clinicaltrials |
| NCT06958445 | Prevention of Oral Mucositis and Improvement of Quality of Life for Patients With Breast Cancer Undergoing Adjuvant Radiotherapy(SAFE) | enrolling by invitation | Phase 2 | 90 | Taipei City HospitalOTHER_GOV | 1 | May 6, 2025 |
| clinicaltrials |
| NCT02646839 | KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children | enrolling by invitation | Phase 2 | 50 | Michael PulsipherOTHER | 1 | May 4, 2025 | clinicaltrials |
| NCT04836390 | Donor-Derived Ex-Vivo Expanded Natural Killer Cell Infusions in Children and Young Adults With High Risk Acute Myeloid Leukemia Receiving Myeloablative HLA-Haploidentical Hematopoietic Cell Transplant(EXCEL) | enrolling by invitation | Phase 2 | 30 | Michael PulsipherOTHER | 1 | May 4, 2025 | clinicaltrials |
| NCT06947096 | Radiomics-Based AI Model for Predicting Para-Aortic Lymph Node Metastasis in Gastric Cancer Patients | enrolling by invitation | — | 120 | Qun ZhaoOTHER | 1 | Apr 27, 2025 | clinicaltrials |
| NCT06943313 | Breast Cancer PET/CT Imaging With 68Ga-pAKTi | enrolling by invitation | — | 20 | Fudan UniversityOTHER | 1 | Apr 24, 2025 | clinicaltrials |
| NCT03423303 | A Randomized Trial of Early Detection of Clinically Significant Prostate Cancer (ProScreen)(ProScreen) | enrolling by invitation | N/A | 17,400 | Tampere UniversityOTHER | 1 | Apr 17, 2025 | clinicaltrials |
| NCT04098640 | Molecular Profiling in Young (<50 Years of Age) Patients With Metastatic Breast Cancer | enrolling by invitation | N/A | 200 | Seoul National University HospitalOTHER | 1 | Apr 17, 2025 | clinicaltrials |
| NCT06931613 | Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment | enrolling by invitation | Phase 2 | 20 | St. Petersburg State Pavlov Medical UniversityOTHER | 1 | Apr 17, 2025 | clinicaltrials |
| NCT06931808 | Intestinal Microbiota Transplantation, Radiochemotherapy and Sintilimab in Localized Advanced Colon Cancer | enrolling by invitation | Phase 4 | 20 | First Affiliated Hospital of Ningbo UniversityNETWORK | 1 | Apr 17, 2025 | clinicaltrials |
| NCT06768268 | A Dose-Image Optimization Trial Evaluating Mannitol and Voluven as Adjuncts for Indocyanine Green(ICGMV) | enrolling by invitation | Phase 1 / Phase 2 | 30 | National Taiwan University HospitalOTHER | 1 | Apr 16, 2025 | clinicaltrials |
| NCT06925685 | Follow-Up for Study Participants Treated With an Allogeneic CAR T-Cell Product | enrolling by invitation | — | 50 | Allogene TherapeuticsINDUSTRY | 1 | Apr 13, 2025 | clinicaltrials |
| NCT06923020 | Association of Nutritional Status With Immune Checkpoint Inhibitor Efficacy in Metastatic Metastatic Esophagogastric Cancer. | enrolling by invitation | — | 200 | Yongxu JiaOTHER | 1 | Apr 11, 2025 | clinicaltrials |
| NCT05706025 | Study to Evaluate EnteroTracker® as a Sampling Method to Screen for Barrett's Esophagus/Esophageal Cancer | enrolling by invitation | N/A | 60 | University of Colorado, DenverOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT06223022 | Nurse-led Proactive Telephone Follow-up With Patients After Completion of Primary Cancer Treatment | enrolling by invitation | N/A | 512 | Umeå UniversityOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT06690216 | Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors(PD-L1-PET) | enrolling by invitation | Phase 1 / Phase 2 | 100 | Man HuOTHER | 1 | Mar 30, 2025 | clinicaltrials |
| NCT06470685 | Prophylactic Prostatectomy for Prostate Cancer (PPPC)(PPPC) | enrolling by invitation | — | 20 | Royal Marsden NHS Foundation TrustOTHER | 1 | Mar 27, 2025 | clinicaltrials |
| NCT06786780 | Establishment and Validation of Prediction Model of Simultaneous Chemoradiotherapy for Cervical Cancer Organoids(ECCO) | enrolling by invitation | Phase 2 | 50 | Chongqing University Cancer HospitalOTHER | 1 | Mar 26, 2025 | clinicaltrials |
| NCT06715501 | Efficacy and Safety of Cadonilimab and Chemoradiotherapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma | enrolling by invitation | N/A | 20 | First Affiliated Hospital of Ningbo UniversityNETWORK | 1 | Mar 25, 2025 | clinicaltrials |
| NCT06890871 | Radiotherapy with Immunotherapy and Anti-Angiogenic Therapy for Advanced HER2-Negative Breast Cancer: a Single-Arm Study | enrolling by invitation | Phase 1 / Phase 2 | 25 | Zhongnan HospitalOTHER | 1 | Mar 24, 2025 | clinicaltrials |
| NCT04915495 | The Use of the LuViva Advanced Cervical Scan to Identify Women at High-Risk for Cervical Neoplasia | enrolling by invitation | N/A | 400 | Guided TherapeuticsINDUSTRY | 1 | Mar 21, 2025 | clinicaltrials |
| NCT06883084 | Clinical Relevance of Pathologic Regression IN Lymph Node for Locally Advanced Rectal Cancer | enrolling by invitation | — | 1,080 | Yanhong DengOTHER | 0 | Mar 19, 2025 | clinicaltrials |
| NCT06883136 | Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients | enrolling by invitation | — | 43 | Qianfoshan HospitalOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT06881550 | Real-world Study on Shenbailing Granules for Improving Qi and Blood Deficiency in Patients After Breast Cancer Surgery | enrolling by invitation | N/A | 2,000 | Caigang LiuOTHER | 1 | Mar 18, 2025 | clinicaltrials |
| NCT03507842 | A Prospective Randomized Comparison of HDAC Vs AD in the Induction Chemothrapy for AML. | enrolling by invitation | Phase 3 | 380 | Asan Medical CenterOTHER | 1 | Mar 17, 2025 | clinicaltrials |
| NCT06560879 | Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children With Leukemia | enrolling by invitation | Phase 2 | 120 | National Institute of Pediatrics, MexicoOTHER_GOV | 1 | Mar 14, 2025 | clinicaltrials |
| NCT06876675 | LORLATINIB-related HYPERLIPIDEMIA in ALK+ Non-Small Cell Lung Cancer | enrolling by invitation | — | 167 | Peking University Third HospitalOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT06505356 | Characterization of Microbiological and Genetic Features in Prostate Cancer and Their Association with Disease Stage | enrolling by invitation | N/A | 400 | Edgaras BurzinskisOTHER | 1 | Mar 13, 2025 | clinicaltrials |
| NCT06447532 | Use of Machine Learning Techniques for Serial Assessment of Systemic Inflammatory Markers in Breast Cancer Patients(INFLAMMATE) | enrolling by invitation | — | 4,500 | Federal University of São PauloOTHER | 8 | Mar 12, 2025 | clinicaltrials |
| NCT06868095 | Multi-Center Study Protocol: Impact of Sarcopenia in Early-Onset Colorectal Cancer.(ISoPECC) | enrolling by invitation | — | 1,000 | Instituto de Investigación Biomédica de SalamancaOTHER | 0 | Mar 12, 2025 | clinicaltrials |
| NCT06870396 | National Study of Adrenal Tumours(NSAT) | enrolling by invitation | — | 300 | Society for EndocrinologyOTHER | 1 | Mar 11, 2025 | clinicaltrials |
| NCT06871007 | Nivolumab and DA-EPOCH-R in Pediatric Primary Mediastinal (Thymic) Large B-cell Lymphoma | enrolling by invitation | Phase 1 / Phase 2 | 22 | St. Petersburg State Pavlov Medical UniversityOTHER | 1 | Mar 11, 2025 | clinicaltrials |
| NCT06863831 | A Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for EC | enrolling by invitation | N/A | 536 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Mar 7, 2025 | clinicaltrials |
| NCT06864572 | [68Ga]Ga-P17-079 in the Diagnosis and Treatment of Metastatic Prostate Cancer | enrolling by invitation | Early Phase 1 | 40 | Peking Union Medical College HospitalOTHER | 1 | Mar 7, 2025 | clinicaltrials |
| NCT06852144 | PET-TC in Thyroid Evaluation(PEPATI-MN-2024) | enrolling by invitation | — | 418 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT06848738 | Improving Genomic Profiling and Reducing Time to Cancer Treatment Via Targeted Use of Endoscopic Ultrasound(IMPROVED) | enrolling by invitation | N/A | 362 | Zealand University HospitalOTHER | 1 | Feb 27, 2025 | clinicaltrials |
| NCT06849362 | Multicenter Retrospective Study on Optimizing Combination Immunotherapy Strategies in MSS/MSI-L/pMMR Advanced Colorectal Cancer | enrolling by invitation | — | 200 | Yue GouOTHER | 1 | Feb 27, 2025 | clinicaltrials |
| NCT06846736 | ALK Digital Pathology Outcome Predition, Multi Institutional, Restrospective Study(ALKDigPath) | enrolling by invitation | — | 200 | Sheba Medical CenterOTHER_GOV | 1 | Feb 26, 2025 | clinicaltrials |
| NCT06405269 | Effect of (neo)Adjuvant Therapy on Lipids in Young Breast Cancer Patients | enrolling by invitation | — | 600 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT06405295 | Intensive Adjuvant Therapy for TNBC with BRCA Gene Mutation | enrolling by invitation | — | 600 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT06793306 | A Study Comparing the Differences Between Young and Non-young Breast Cancer | enrolling by invitation | — | 3,000 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT06828614 | Barriers to Therapeutic Exercise in Breast Cancer Patients Before, During, and After Chemotherapy | enrolling by invitation | — | 111 | University of ValenciaOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT06821490 | Validation of TAD in HER-2 with More Than 2 Lymph Nodes(DAD-HER2) | enrolling by invitation | — | 21 | Fundación para la Investigación del Hospital Clínico de ValenciaOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT01868490 | The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells | enrolling by invitation | Phase 1 / Phase 2 | 20 | Siriraj HospitalOTHER | 1 | Feb 10, 2025 | clinicaltrials |
| NCT05674539 | Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome | enrolling by invitation | Phase 3 | 200 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Feb 10, 2025 | clinicaltrials |
| NCT06816966 | Chemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLC(CISART) | enrolling by invitation | Phase 2 | 35 | Fujian Medical University Union HospitalOTHER | 1 | Feb 10, 2025 | clinicaltrials |
| NCT06814353 | Intraoperatively Observed Site of Origin and Growth Pattern of Medulloblastoma(ISOP) | enrolling by invitation | — | 100 | Christian DorferOTHER | 3 | Feb 7, 2025 | clinicaltrials |
| NCT06809673 | PA.RI.GE. Study. The Prognostic Role of Inflammatory Circulating Biomarkers in HNSCC: a Prospective Multicentric Trial | enrolling by invitation | — | 400 | Ospedale Policlinico San MartinoOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT06723665 | The Exploration of 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients | enrolling by invitation | N/A | 50 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT06774170 | Structured Follow-up Intervention on Glucose Status After Pancreatic Cancer Surgery(FiGluR) | enrolling by invitation | N/A | 40 | Dokuz Eylul UniversityOTHER | 1 | Jan 23, 2025 | clinicaltrials |
Data updated 22 days agoSource updated May 8, 2025source: clinicaltrials